Boston Partners Has $39.29 Million Position in Maximus, Inc. $MMS

Boston Partners raised its stake in Maximus, Inc. (NYSE:MMS) by 80.5% during the second quarter, HoldingsChannel reports. The institutional investor owned 555,500 shares of the health services provider’s stock after acquiring an additional 247,782 shares during the period. Boston Partners’ holdings in Maximus were worth $39,293,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in MMS. Caitong International Asset Management Co. Ltd boosted its holdings in Maximus by 17,533.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider’s stock valued at $36,000 after acquiring an additional 526 shares during the last quarter. UMB Bank n.a. boosted its stake in shares of Maximus by 37.5% in the 2nd quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock valued at $58,000 after purchasing an additional 227 shares during the last quarter. Bayforest Capital Ltd acquired a new stake in shares of Maximus during the second quarter worth $61,000. Parkside Financial Bank & Trust raised its stake in Maximus by 21.7% during the second quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock worth $62,000 after buying an additional 157 shares during the last quarter. Finally, GAMMA Investing LLC lifted its holdings in Maximus by 60.4% in the second quarter. GAMMA Investing LLC now owns 1,174 shares of the health services provider’s stock valued at $82,000 after buying an additional 442 shares during the period. Institutional investors and hedge funds own 97.21% of the company’s stock.

Insider Activity

In related news, insider Michelle F. Link sold 1,610 shares of the stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the transaction, the insider directly owned 13,508 shares in the company, valued at $1,227,336.88. This trade represents a 10.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on MMS. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 27th. Weiss Ratings upgraded Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Maximus has a consensus rating of “Moderate Buy” and a consensus target price of $90.00.

Maximus Stock Performance

Shares of MMS opened at $80.54 on Thursday. The stock has a 50-day moving average of $87.00 and a 200-day moving average of $78.91. Maximus, Inc. has a one year low of $63.77 and a one year high of $92.50. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. The company has a market cap of $4.54 billion, a PE ratio of 14.83 and a beta of 0.57.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date of this dividend is Friday, November 14th. Maximus’s dividend payout ratio is presently 22.10%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.